Evid Invest
Holders — by stockHoldings — by fund

Carlyle Group Inc.

Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0001527166

$8.36B

disclosed book value

16

positions

77.6%

largest position share

Positions, as of 2026-09-30

top 16 of 16 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held

#IssuerSharesValue% of book
1MDLNMedline Inc187.1M$6.49B77.6%
2SAROStandardaero Inc84.6M$1.81B21.6%
3PHATPhathom Pharmaceuticals Inc3.5M$25.5M0.3%
4PONYPony Ai Inc2.4M$15.5M0.2%
5INVHInvitation Homes Inc477,500$12.6M0.2%
6SPRBSpruce Biosciences Inc38,620$1.9M0%
7FWRDForward Air Corp107,214$1.6M0%
8ACETAdicet Bio Inc184,295$1.3M0%
9HOODRobinhood Mkts Inc8,767$986,2880%
10DNUTKrispy Kreme Inc340,748$977,9470%
11OKUROnkure Therapeutics Inc269,895$735,4640%
12SPWRSunPower Inc2.3M$719,7660%
13JSPRJasper Therapeutics Inc1.1M$618,3900%
14METCRamaco Res Inc52,922$437,6690%
15NBISNebius Group N.V.1,846$435,4340%
16NABLN-able Inc93,732$384,3010%

Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.